{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:43:18Z","timestamp":1790080998374,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JIMRO Co Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jaad.2012.09.037","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T18:17:18Z","timestamp":1358446638000},"page":"609-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis"],"prefix":"10.1016","volume":"68","author":[{"given":"Shigaku","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Etoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Seishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutomo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kanekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.09.037_bib1","first-page":"11","article-title":"Psoriasis\u2013new insights into pathogenesis and treatment","volume":"106","author":"Mrowietz","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaad.2012.09.037_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4140\/TCP.n.2012.86","article-title":"Psoriasis: issues far more serious than cosmetic","volume":"27","author":"Zanni","year":"2012","journal-title":"Consult Pharm"},{"key":"10.1016\/j.jaad.2012.09.037_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lpm.2011.09.026","article-title":"Psoriasis: a systemic disease","volume":"41","author":"Bens","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2012.09.037_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3899\/jrheum.111240","article-title":"Strategies for biomarker development in psoriatic disease: a report from the GRAPPA 2010 Annual Meeting","volume":"39","author":"Ritchlin","year":"2012","journal-title":"JRheumatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib5","article-title":"A cutting edge overview: psoriatic disease","author":"Raychaudhuri","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2012.09.037_bib6","series-title":"Rook's textbook of dermatology","first-page":"35.51","article-title":"Psoriasis","author":"Griffiths","year":"2004"},{"key":"10.1016\/j.jaad.2012.09.037_bib7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1346-8138.2011.01279.x","article-title":"Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis","volume":"38","author":"Shukuya","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1744-9987.2007.00536.x","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis","volume":"12","author":"Seishima","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2012.09.037_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ecn.2011.0294","article-title":"Cytokine network in psoriasis revisited","volume":"22","author":"Michalak-Stoma","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaad.2012.09.037_bib10","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2174\/138920112802273281","article-title":"Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target","volume":"13","author":"Botti","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jaad.2012.09.037_bib11","doi-asserted-by":"crossref","first-page":"e30308","DOI":"10.1371\/journal.pone.0030308","article-title":"Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs","volume":"7","author":"Johnson-Huang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2012.09.037_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2230.2011.04181.x","article-title":"Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease","volume":"37","author":"Yoshifuku","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaad.2005.01.105","article-title":"Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis","volume":"52","author":"Kanekura","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1744-9987.2006.00369.x","article-title":"Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils","volume":"10","author":"Kanekura","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2012.09.037_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1744-9987.2011.00961.x","article-title":"Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis","volume":"15","author":"Fujisawa","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2012.09.037_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.20305","article-title":"High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract","volume":"40","author":"Viguier","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2012.09.037_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2012.09.037_bib18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1572-0241.2003.07657.x","article-title":"Treatment of pyoderma gangrenosum associated with Crohn's disease","volume":"98","author":"Ohmori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leukocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaad.2012.09.037_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04279.x","article-title":"The mode of actions of the Adacolumn therapeutic leukocytapheresis in patients with inflammatory bowel disease: a concise review","volume":"163","author":"Hanai","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2012.09.037_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crohns.2012.02.005","article-title":"The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscesses","volume":"6","author":"Kato","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaad.2012.09.037_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1684\/ejd.2011.1461","article-title":"Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis","volume":"21","author":"Ikeda","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jaad.2012.09.037_bib24","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ajg.2009.453","article-title":"An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment","volume":"104","author":"Sakuraba","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","article-title":"Granulocyteapheresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study","volume":"20","author":"Dom\u00e8nech","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2012.09.037_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","article-title":"A randomized, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis","volume":"135","author":"Sands","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2012.09.037_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00535-011-0428-4","article-title":"Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study","volume":"4688","author":"Yamamoto","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00054725-200608000-00008","article-title":"Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings","volume":"12","author":"Yamamoto","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2012.09.037_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.dld.2008.11.020","article-title":"Treating ulcerative colitis by Adacolumn therapeutic leukocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centers in Japan","volume":"41","author":"Hibi","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaad.2012.09.037_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1526-0968.2004.00086.x","article-title":"Detection of specific IgE antibodies to nafamostat mesylate as an induction of possible adverse effects of leukocytapheresis using nafamostat mesylate as anticoagulant","volume":"8","author":"Nagase","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2012.09.037_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.929193","article-title":"Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis","volume":"198","author":"Lazarus","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.jaad.2012.09.037_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/1523-1747.ep12470558","article-title":"Electron microscopic features in generalized pustular psoriasis","volume":"89","author":"Heng","year":"1987","journal-title":"Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1346-8138.2010.01018.x","article-title":"Serum levels of interleukin-8, tumor necrosis factor-\u03b1 and \u03b3-interferon in Egyptian psoriatic patients and correlation with disease severity","volume":"38","author":"Abdel-Hamid","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib36","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood.V96.12.3958","article-title":"Expression of CCR6 and CD83 by cytokine-activated human neutrophils","volume":"96","author":"Yamashiro","year":"2000","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.09.037_bib37","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","article-title":"Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity","volume":"295","author":"Umezawa","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2012.09.037_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs methotrexate vs placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/08923973.2011.653646","article-title":"Safety of anti\u2013TNF\u03b1 agents in the treatment of psoriasis and psoriatic arthritis","volume":"34","author":"Girolomoni","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaad.2012.09.037_bib40","article-title":"Etanercept use for psoriasis in Taiwan: a case series study","author":"Chiu","year":"2012","journal-title":"Int J Pharmacol"},{"key":"10.1016\/j.jaad.2012.09.037_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","article-title":"The production of cytokines by polymorphonuclear neutrophils","volume":"16","author":"Cassatella","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2012.09.037_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2012.09.037_bib43","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2036.2011.04866.x","article-title":"Psoriasis associated with anti\u2013tumor necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature","volume":"34","author":"Cullen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2012.09.037_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.09.037_bib45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib46","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2012.09.037_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-004-1253-5","article-title":"Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin","volume":"53","author":"Takeda","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaad.2012.09.037_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: interleukin 1 receptor antagonist in\u00a0vivo and in\u00a0vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2012.09.037_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.103.054106","article-title":"Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats","volume":"307","author":"Tahara","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2012.09.037_bib50","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF","volume":"168","author":"Belge","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2012.09.037_bib51","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1572-0241.2007.01714.x","article-title":"Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease","volume":"103","author":"Hanai","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib52","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.14.1521","article-title":"Regulatory T cells in patients with inflammatory bowel diseases treated with Adacolumn granulocytapheresis","volume":"14","author":"Cuadrado","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2012.09.037_bib53","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s10620-006-9560-z","article-title":"Demonstration of low CD25High+CD4+ and high CD28\u2212CD4+ T-cell subsets in patients with ulcerative colitis: modified by selective leukocytapheresis","volume":"52","author":"Yokoyama","year":"2007","journal-title":"Dig Dis Sci"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212010420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212010420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:26:30Z","timestamp":1759271190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212010420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0190962212010420"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.037","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}